KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Enterprise Value (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Enterprise Value for 11 consecutive years, with -$285.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Enterprise Value rose 56.56% year-over-year to -$285.4 million, compared with a TTM value of -$285.4 million through Sep 2025, up 56.56%, and an annual FY2024 reading of -$669.4 million, down 172.74% over the prior year.
  • Enterprise Value was -$285.4 million for Q3 2025 at Medpace Holdings, down from -$46.3 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$28.3 million in Q4 2022 and bottomed at -$669.4 million in Q4 2024.
  • Average Enterprise Value over 5 years is -$271.6 million, with a median of -$285.4 million recorded in 2025.
  • The sharpest move saw Enterprise Value surged 93.87% in 2022, then tumbled 1205.37% in 2024.
  • Year by year, Enterprise Value stood at -$461.3 million in 2021, then soared by 93.87% to -$28.3 million in 2022, then plummeted by 768.38% to -$245.4 million in 2023, then plummeted by 172.74% to -$669.4 million in 2024, then skyrocketed by 57.37% to -$285.4 million in 2025.
  • Business Quant data shows Enterprise Value for MEDP at -$285.4 million in Q3 2025, -$46.3 million in Q2 2025, and -$441.4 million in Q1 2025.